The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 96.80
Bid: 96.60
Ask: 96.75
Change: -1.40 (-1.43%)
Spread: 0.15 (0.155%)
Open: 97.90
High: 97.90
Low: 96.00
Prev. Close: 98.20
SRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cash fraction applicable to the Scrip Dividend

7 Jul 2022 10:00

RNS Number : 6642R
Sirius Real Estate Limited
07 July 2022
 

SIRIUS REAL ESTATE LIMITED

(Incorporated in Guernsey)

Company Number: 46442

JSE Share Code: SRE

LSE (GBP) Share Code: SRE

ISIN Code: GG00B1W3VF54

LEI: 213800NURUF5W8QSK566

 

7 July 2022

Sirius Real Estate Limited

("Sirius Real Estate" or the "Company")

Cash fraction applicable to the Scrip Dividend

Shareholders of the Company ("Shareholders") are referred to the condensed consolidated financial results for the year ended 31 March 2022, published on RNS and SENS on 13 June 2022, in which the Company declared a cash dividend with the alternative to elect to receive a scrip dividend ("Scrip Dividend Alternative") and the Shareholder Circular dated 20 June 2022, relating to the Scrip Dividend Alternative.

The attention of Shareholders is accordingly drawn to the following terms relating to the fractions applicable to the Scrip Dividend Alternative.

Shareholders on the UK Register

Where the operation of the Scrip Dividend Alternative would result in a Share Elector being entitled to less than one New Share (for example where that Share Elector held a small number of Ordinary Shares) no fraction of a New Share will be issued, and the relevant amount of authorised Dividend will be retained for the benefit of the Company. 

Shareholders on the SA Register

No fractions of a New Share will be issued to Shareholders on the SA Register.

You cannot accumulate residual entitlements or receive a fraction of a New Share. Where you have made an election to participate in the Scrip Dividend Alternative, which would otherwise give rise to an entitlement to a fraction of a New Share, the number of New Shares to be received will be rounded down and any residual entitlement which is less than the price of one New Share (as calculated in accordance with paragraph 3 of the terms and conditions set out in the Circular) will be paid to you in cash in Rand.

 

The cash fractional payment was determined with reference to the volume weighted traded price on the JSE on, Wednesday, 6 July 2022 (being the date on which the Ordinary Shares began trading on the JSE ex the cash dividend or scrip dividend) of 1,754.65875 ZAR Cents, discounted by 10% ("Fractional Reference Price"). Shareholders are accordingly advised that the Fractional Reference Price is 1,579.19288 ZAR Cents (1,754.65875 ZAR Cents discounted by 10%). The cash fractional payment may be considered to be revenue or capital in nature and will depend on the nature of the pre-existing Ordinary Shares held by Shareholders of the Company. The cash fractional payment is not regarded as a dividend for South African tax purposes and will not be subject to dividends tax. Shareholders are advised to seek their own tax advice from an independent tax adviser should they be in any doubt as to the tax treatment for them of any cash fractional payment.

Further Information

Terms used but not defined herein have the same meaning given to them as set out in the Circular.

The distribution of the Circular in certain jurisdictions (including the United States of America, Canada, Japan, New Zealand or Australia or their respective territories or possessions (subject to applicable exemptions)) other than the United Kingdom, South Africa and Guernsey may be restricted by law. Accordingly, the Circular may not be distributed or published in any jurisdiction except under circumstances that will result in compliance with any applicable laws and regulations. Persons into whose possession the Circular comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

For further information:

 

Sirius Real Estate

Andrew Coombs, CEO

Diarmuid Kelly, CFO

 

 

 

+49 (0)30 285010110

FTI Consulting (financial PR)

Richard Sunderland

Talia Jessener

SiriusRealEstate@fticonsulting.com

 

(+44) 020 3727 1000

 

 

JSE Sponsor

PSG Capital

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFEDDVIDIIF
Date   Source Headline
29th Mar 20234:15 pmRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSAppointment of new Chief Financial Officer
22nd Mar 20237:00 amRNSNotice of Trading Update
13th Feb 20237:00 amRNSChange of Registered Office Address
27th Jan 20237:00 amRNSDirector/PDMR Shareholding
18th Jan 20231:00 pmRNSDirector/PDMR Shareholding
15th Dec 202212:34 pmEQSProactive research analyst on Sirius Real Estate
30th Nov 20222:00 pmRNSTotal Voting Rights
23rd Nov 20222:00 pmRNSAllotment of 2018 Long Term Incentive Plan Shares
21st Nov 20222:33 pmEQSSirius Real Estate dividend tracks FFO higher
21st Nov 20227:00 amRNSHalf-year Report
17th Nov 20227:00 amRNSTrading Statement
7th Nov 20222:30 pmRNSFITCH REAFFIRMS SIRIUS’ BBB INVESTMENT RATING
27th Oct 202210:00 amRNSHolding(s) in Company
24th Oct 202212:00 pmRNSHolding(s) in Company
10th Oct 20227:01 amRNSSouth Africa Roadshow
10th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSEARLY REFINANCING OF NEXT MAJOR DEBT EXPIRY
4th Oct 202212:00 pmRNSHolding(s) in Company
4th Oct 202211:43 amRNSACQUISITIONS AND DISPOSALS UPDATE
30th Sep 20222:00 pmRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSNotice of Trading Update
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20223:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20222:00 pmRNSDirector/PDMR Shareholding
20th Sep 202212:00 pmRNSHolding(s) in Company
15th Sep 202210:00 amRNSDirector/PDMR Shareholding
8th Sep 20224:00 pmRNSDealing in Securities
8th Sep 202210:00 amRNSHolding(s) in Company
5th Sep 20224:00 pmRNSDirector/PDMR Shareholding
31st Aug 20222:00 pmRNSTotal Voting Rights
25th Aug 20222:00 pmRNSDirector/PDMR Shareholding
18th Aug 20222:00 pmRNSDirector/PDMR Shareholding
18th Aug 20229:00 amRNSAdmission of Scrip Shares
16th Aug 20228:30 amRNSCHANGE OF CHIEF FINANCIAL OFFICER (“CFO”)
10th Aug 20222:00 pmRNSDividend & Allotment of Scrip Dividend
3rd Aug 20224:15 pmRNSDirector/PDMR Shareholding
29th Jul 20223:00 pmRNSTotal Voting Rights
21st Jul 20223:00 pmRNSDirector/PDMR Shareholding
19th Jul 20223:00 pmRNSDirector/PDMR Shareholding
18th Jul 20223:00 pmRNSAllotment of 2018 Long Term Incentive Plan Shares
12th Jul 20223:00 pmRNSDirector/PDMR Shareholding
12th Jul 202211:00 amRNSDirector/PDMR Shareholding
11th Jul 202211:00 amRNSHolding(s) in Company
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:00 amRNSDealing in Securities
7th Jul 20224:00 pmRNSDirector/PDMR Shareholding
7th Jul 202210:00 amRNSCash fraction applicable to the Scrip Dividend
7th Jul 20227:00 amRNSSIRIUS COMPLETES £16M SALE OF BIZSPACE CAMBERWELL
6th Jul 20224:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.